395 filings
Page 3 of 20
8-K
094ixejuam6cd0qbds
7 Mar 23
Termination of a Material Definitive Agreement
8:55am
8-K
4m3ut5lvdei6ectzyes
17 Jan 23
Ampio Pharmaceuticals Issues Letter to Stockholders
8:30am
8-K
g1koy2 dzamd4x7b
27 Dec 22
Regulation FD Disclosure
5:18pm
8-K
3pokrqm1ablzcut
18 Nov 22
Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension
4:26pm
8-K
djyca8n1
9 Nov 22
Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split
4:22pm
8-K
iar9psrles0qu8m1t
14 Oct 22
Ampio Pharmaceuticals Issues Letter to Stockholders
4:15pm
DEFA14A
b8dc 12il
4 Oct 22
Additional proxy soliciting materials
9:07am
DEFA14A
arp66fsegri2jgsokvs
4 Oct 22
Additional proxy soliciting materials
8:59am
8-K
qy584rzjbsmunc8pcpy6
4 Oct 22
Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings
8:51am
8-K
a6vyid1feuws
1 Sep 22
Departure of Directors or Certain Officers
4:52pm
8-K
mh6oydxq
12 Aug 22
Submission of Matters to a Vote of Security Holders
7:01am
DEFA14A
qwva 1my9c
4 Aug 22
Additional proxy soliciting materials
8:52am
DEFA14A
nddfku714y7pg 1q
3 Aug 22
Additional proxy soliciting materials
8:39am
8-K
63metez
3 Aug 22
Ampio Pharmaceuticals’ Chairman of the Board Kevin Buchi and CEO Mike Martino Issues Letter to Stockholders
8:36am
DEFA14A
uwhl2m
5 Jul 22
Additional proxy soliciting materials
8:56am